Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer

Overview of attention for article published in Clinical Epigenetics, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 89,314 followers.

RT @BioMedCentral: DNA methylation presents itself as a potentially strong biomarker to further improve prognostic power in clear cell rena…

25 Jan 2021

Reply Repost Favourite

DNA methylation presents itself as a potentially strong biomarker to further improve prognostic power in clear cell renal cell carcinoma patients with a low risk Necrosis score, reports a study published in Clinical Epigenetics. https://t.co/wbUW2VwB5B

25 Jan 2021

Reply Repost Favourite

Fantastic research from @UniNorthants former PhD researcher and postdoc @detective_louis #cancer #epigenetics

20 Jan 2021

Reply Repost Favourite

New article: Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. https://t.co/HQopmh7nYO #kidneycancer #oncology https://t.co/kq2wMhbB4Q

20 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.